THERMO FISHER SCIENTIFIC INC. (TMO) Revenue from Contract with Customer, Excluding Assessed Tax USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Thermo Fisher Scientific Inc. quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2016 to 2024.
  • Thermo Fisher Scientific Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending March 30, 2024 was $10.3B, a 3.41% decline year-over-year.
  • Thermo Fisher Scientific Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending March 30, 2024 was $42.5B, a 3% decline year-over-year.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $10.3B -$365M -3.41% Jan 1, 2024 Mar 30, 2024 10-Q 2024-05-03
Q4 2023 $10.9B -$564M -4.93% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q4 2023 $42.9B -$2.06B -4.58% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $10.6B -$103M -0.97% Jul 2, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $10.7B -$283M -2.58% Apr 2, 2023 Jul 1, 2023 10-Q 2023-08-04
Q1 2023 $10.7B -$1.11B -9.38% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-03
Q4 2022 $11.5B +$748M +6.99% Oct 2, 2022 Dec 31, 2022 10-K 2024-02-22
Q4 2022 $44.9B +$5.7B +14.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $10.7B +$1.35B +14.4% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-03
Q2 2022 $11B +$1.7B +18.3% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-04
Q1 2022 $11.8B +$1.91B +19.3% Jan 1, 2022 Apr 2, 2022 10-Q 2023-05-05
Q4 2021 $10.7B +$152M +1.44% Oct 3, 2021 Dec 31, 2021 10-K 2024-02-22
Q4 2021 $39.2B +$6.99B +21.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $9.33B +$809M +9.49% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-04
Q2 2021 $9.27B +$2.36B +34.1% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-05
Q1 2021 $9.91B +$3.68B +59% Jan 1, 2021 Apr 3, 2021 10-Q 2022-05-06
Q4 2020 $10.6B +$3.72B +54.5% Sep 27, 2020 Dec 31, 2020 10-K 2023-02-23
Q4 2020 $32.2B +$6.68B +26.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $8.52B +$2.25B +35.9% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-04
Q2 2020 $6.92B +$601M +9.52% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-06
Q1 2020 $6.23B +$105M +1.71% Jan 1, 2020 Mar 28, 2020 10-Q 2021-05-07
Q4 2019 $6.83B +$322M +4.95% Sep 29, 2019 Dec 31, 2019 10-K 2020-02-26
Q4 2019 $25.5B +$1.18B +4.86% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $6.27B +$352M +5.95% Jun 30, 2019 Sep 28, 2019 10-Q 2020-10-30
Q2 2019 $6.32B +$238M +3.92% Mar 31, 2019 Jun 29, 2019 10-Q 2020-07-31
Q1 2019 $6.13B +$272M +4.65% Jan 1, 2019 Mar 30, 2019 10-Q 2020-05-01
Q4 2018 $6.51B +$460M +7.61% Sep 30, 2018 Dec 31, 2018 10-K 2020-02-26
Q4 2018 $24.4B +$3.44B +16.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $5.92B +$804M +15.7% Jul 1, 2018 Sep 29, 2018 10-K 2020-02-26
Q2 2018 $6.08B +$1.09B +21.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 $5.85B +$1.09B +22.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 $6.05B Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q4 2017 $20.9B +$2.64B +14.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $5.12B Jul 2, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 $4.99B Apr 2, 2017 Jul 1, 2017 10-K 2019-02-27
Q1 2017 $4.77B Jan 1, 2017 Apr 1, 2017 10-K 2019-02-27
Q4 2016 $18.3B Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.